Outcomes of combination therapy for stage IIA–IIIB cervical cancer

Outcomes of combination therapy for stage IIA–IIIB cervical cancer

Objective: to analyze treatment outcomes in patients with stage IIA–IIIB cervical cancer. Materials and methods. The study included 278 women with stage IIA–IIIB cervical cancer. Study participants were divided into 2 groups. Group 1 comprised 165 patients who received chemoradiotherapy + surgery (r...

Full description

Saved in:
Bibliographic Details
Published in:Opukholi zhenskoĭ reproduktivnoĭ sistemy Vol. 14; no. 4; pp. 50 - 55
Main Authors: Reyes Santiago, D. K., Khadzhimba, A. S., Sobolev, I. V., Ilyin, A. A., Maksimov, S. Ya
Format: Journal Article
Language:English
Published: ABV-press 21-02-2019
Subjects:
cervical cancer
chemoradiotherapy
combination therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective: to analyze treatment outcomes in patients with stage IIA–IIIB cervical cancer. Materials and methods. The study included 278 women with stage IIA–IIIB cervical cancer. Study participants were divided into 2 groups. Group 1 comprised 165 patients who received chemoradiotherapy + surgery (radical hysterectomy). Patients in group 2 received standard radiotherapy. Results. Patients receiving combination therapy demonstrated better overall and relapse-free survival compared to those receiving standard treatment. Conclusion. Both publications of other authors and our own results suggest high efficacy and safety of combination therapy for stage IIA–IIIB cervical cancer.
ISSN:1994-4098
1999-8627
DOI:10.17650/1994-4098-2018-14-4-50-55